Literature DB >> 30242438

[Modern wound treatment-from best practice to innovation].

N Kirsten1, K Herberger1,2, M Augustin1,2, W Tigges3, C Behrendt4, F Heidemann4, E S Debus4,1, H Diener5,6.   

Abstract

According to the Research Group for Primary Medical Care (PMV), approximately 890,000 people in Germany were suffering from a chronic wound in 2012. This corresponds to a prevalence of 1.1%. Ulcus cruris, diabetic ulcers and decubital ulcers are among the most frequent causes of chronic wounds (57-80%). The guarantee for successful wound care is based on a good understanding of the physiology of the wound healing process. A disorder of the phase-like course can lead to complications, delays or suspension of wound healing. There are many reasons for pathological wound healing including infections, oxygen deficiency and non-phase-adapted wound care. In addition to established wound products, innovative products such as dermal matrixes, cold plasma therapy and platelet-rich plasma represent promising therapeutic alternatives for non-healing chronic wounds.

Entities:  

Keywords:  Cold plasma; Dermal matrix; Fish skin dermal matrix; Non-healing wounds; Platelet rich plasma

Mesh:

Year:  2018        PMID: 30242438     DOI: 10.1007/s00104-018-0731-1

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  24 in total

Review 1.  Cutaneous wound healing.

Authors:  A J Singer; R A Clark
Journal:  N Engl J Med       Date:  1999-09-02       Impact factor: 91.245

Review 2.  Effectiveness of advanced versus conventional wound dressings on healing of chronic wounds: systematic review and meta-analysis.

Authors:  K Heyer; M Augustin; K Protz; K Herberger; C Spehr; S J Rustenbach
Journal:  Dermatology       Date:  2013-05-22       Impact factor: 5.366

3.  The topical use of non-thermal dielectric barrier discharge (DBD): nitric oxide related effects on human skin.

Authors:  Kiara Heuer; Martin A Hoffmanns; Erhan Demir; Sabrina Baldus; Christine M Volkmar; Mirco Röhle; Paul C Fuchs; Peter Awakowicz; Christoph V Suschek; Christian Opländer
Journal:  Nitric Oxide       Date:  2014-11-27       Impact factor: 4.427

4.  Healing rate and autoimmune safety of full-thickness wounds treated with fish skin acellular dermal matrix versus porcine small-intestine submucosa: a noninferiority study.

Authors:  Baldur Tumi Baldursson; Hilmar Kjartansson; Fífa Konrádsdóttir; Palmar Gudnason; Gudmundur F Sigurjonsson; Sigrún Helga Lund
Journal:  Int J Low Extrem Wounds       Date:  2015-03-09       Impact factor: 2.057

5.  A clinical trial of Integra Template for diabetic foot ulcer treatment.

Authors:  Vickie R Driver; Lawrence A Lavery; Alexander M Reyzelman; Timothy G Dutra; Cyaandi R Dove; Sandra V Kotsis; Hyungjin Myra Kim; Kevin C Chung
Journal:  Wound Repair Regen       Date:  2015-10-19       Impact factor: 3.617

6.  Regenerative and Antibacterial Properties of Acellular Fish Skin Grafts and Human Amnion/Chorion Membrane: Implications for Tissue Preservation in Combat Casualty Care.

Authors:  Skuli Magnusson; Baldur Tumi Baldursson; Hilmar Kjartansson; Ottar Rolfsson; Gudmundur Fertram Sigurjonsson
Journal:  Mil Med       Date:  2017-03       Impact factor: 1.437

7.  [A standard data set for the evaluation of venous leg ulcers in selective contracts : National consensus].

Authors:  K Heyer; S Milde; J Schmitt; M May; J Helfrich; M Augustin
Journal:  Hautarzt       Date:  2017-10       Impact factor: 0.751

Review 8.  [Atypical wounds: definition and classification].

Authors:  Mirna Situm; Maja Kolić
Journal:  Acta Med Croatica       Date:  2012-10

Review 9.  Non-thermal atmospheric-pressure plasma possible application in wound healing.

Authors:  Beate Haertel; Thomas von Woedtke; Klaus-Dieter Weltmann; Ulrike Lindequist
Journal:  Biomol Ther (Seoul)       Date:  2014-11-30       Impact factor: 4.634

10.  A prospective, randomised, controlled, multicentre clinical trial examining healing rates, safety and cost to closure of an acellular reticular allogenic human dermis versus standard of care in the treatment of chronic diabetic foot ulcers.

Authors:  Charles M Zelen; Dennis P Orgill; Thomas Serena; Robert Galiano; Marissa J Carter; Lawrence A DiDomenico; Jennifer Keller; Jarrod Kaufman; William W Li
Journal:  Int Wound J       Date:  2016-04-12       Impact factor: 3.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.